Biotech

All Articles

Analysts dig into Avidity's DMD succeed, uncovering distinctions in data

.Avidity Biosciences pleased clients with phase 1/2 information in Duchenne muscle dystrophy (DMD) F...

Actinogen's cortisol blocker fails period 2 clinical depression research

.Actinogen Medical's cortisol blocker has overlooked the main endpoint of a stage 2 research in depr...

Bivictrix decides going personal only method to take ADC right into medical clinic

.Antibody-drug conjugates (ADCs) have actually been at the center of lots of a billion-dollar biobuc...

TPG leadings up funds to $580M for expenditures throughout life scientific researches

.Possession supervisor TPG, which has sustained biotechs like Sionna Rehabs as well as Santa Clam An...

Merck stops phase 3 TIGIT trial in lung cancer for futility

.Merck &amp Co.'s TIGIT plan has actually endured an additional problem. Months after shuttering a p...

After a challenging year, Exscientia folds up into Recursion

.After a year defined by pipe hairstyles, the shift of its chief executive officer and unemployments...

Cullinan, after $25M deal, return bispecific to Port

.Cullinan Therapy was actually made an impression on good enough along with Port BioMed's bispecific...

A more detailed consider Intense Biotech's Tough 15

.In this particular full week's incident of "The Top Line," we are actually diving into Intense Biot...

Lilly encounters period 2 failure of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's gathering celebrating the approval of Alzheim...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of significant leadership hirings, firings a...